21 CFR Part 884 · Obstetrical and Gynecological Devices

21 CFR 884.5970

Clitoral engorgement device

21 CFR 884.5970 is the regulation titled “Clitoral engorgement device” in 21 CFR Part 884, Obstetrical and Gynecological Devices. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 807.81, in 1 letter
Closed out
100% of these letters have a published close-out
See the letter citing 21 CFR 884.5970 →

Letters citing it, by year issued

It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 12024
  5. 02025
  6. 02026

The regulation

Read the text of 21 CFR 884.5970 (eCFR, as of Sep 1, 2026)

(a) Identification. A clitoral engorgement device is designed to apply a vacuum to the clitoris. It is intended for use in the treatment of female sexual arousal disorder.

(b) Classification. Class II (special controls). The special control is a guidance document entitled: “Guidance for Industry and FDA Reviewers: Class II Special Controls Guidance Document for Clitoral Engorgement Devices.”

[65 FR 47306, Aug. 2, 2000]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 884.5970.

Latest letters citing it

The letter citing 21 CFR 884.5970 that FDA posted most recently.

See the letter citing 21 CFR 884.5970 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.